Fate Therapeutics Inc (FATE)

Cost of Revenue

$28.76M

TTM · Period ending: · USD

FATE logo

FATE Cost of Revenue

Latest reported$28.76M
FATE TTM Cost of Revenue ($12.01M → $28.76M)
High-resolution chart · PNG

FATE cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Fate Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
28,756,000
32,577,000
58,795,000
75,934,000
84,746,000
85,646,000
61,331,000
49,077,000
19,167,000
55,322,000
116,130,000
198,436,000
273,513,000
313,944,000
320,454,000
302,778,000
276,091,000
242,807,000
215,520,000
184,987,000
162,551,000
141,197,000
125,623,000
86,641,000
79,149,000
74,111,000
62,561,000
76,656,000
67,091,000
62,276,000
56,024,000
51,816,000
46,757,000
37,868,000
34,358,000
30,701,000
28,927,000
27,782,000
26,452,000
25,655,000
23,854,000
21,929,000
19,861,000
18,293,000
17,370,000
16,481,000
16,435,000
15,601,000
14,899,000
13,998,000
12,007,000
12,379,000
12,316,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.